US201 Study: A Phase 2, Randomized Proof-of-Concept Trial of Favipiravir for the Treatment of COVID-19

por Finberg, Robert W, Ashraf, Madiha, Julg, Boris, Ayoade, Folusakin, Marathe, Jai G, Issa, Nicolas C, Wang, Jennifer P, Jaijakul, Siraya, Baden, Lindsey R, Epstein, Carol
Publicado 2021

Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma

por Salazar, Eric, Perez, Katherine K., Ashraf, Madiha, Chen, Jian, Castillo, Brian, Christensen, Paul A., Eubank, Taryn, Bernard, David W., Eagar, Todd N., Long, S. Wesley, Subedi, Sishir, Olsen, Randall J., Leveque, Christopher, Schwartz, Mary R., Dey, Monisha, Chavez-East, Cheryl, Rogers, John, Shehabeldin, Ahmed, Joseph, David, Williams, Guy, Thomas, Karen, Masud, Faisal, Talley, Christina, Dlouhy, Katharine G., Lopez, Bevin V., Hampton, Curt, Lavinder, Jason, Gollihar, Jimmy D., Maranhao, Andre C., Ippolito, Gregory C., Saavedra, Matthew O., Cantu, Concepcion C., Yerramilli, Prasanti, Pruitt, Layne, Musser, James M.
Publicado 2020